drugset / Trial / NCT04744636

Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus

NCT04744636

Phase 1 Completed 100 enrolled Servier ADIR, a Servier Group company · collab
Non-randomizedParallel-groupOpen-labelOther

Summary

The purpose of this study is to evaluate the vascular function and biomarkers in healthy volunteers and type 2 diabetic patients.

Timeline

Start
2017-04-03
Primary completion
2018-09-15
Completion
2018-09-15

Drugs

EvaluationDrugModalityDoseRoute
Background Acetylcholine Small molecule Subcutaneous
Background Adenosine Small molecule Intravenous